http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Celgene and Acceleron Announce New Results from an Investigational Study with Luspatercept in Myelodysplastic Syndromes Presented at the 57th American Society of Hematology (ASH) Annual Meeting and Ex
-
Study of Bortezomib Added to Revlimid® and Dexamethasone Backbone Therapy Presented at ASH
-
Top 10 News for 7/13 - 7/17: Greece Caves to Creditors' Demands; Yellen Looks for Rate Hike in '15; Tesla's Latest Update is 'Ludicrous'
-
Market Wrap: DJIA Climbs Back Over 18k; Retail Sales Miss in June; Twitter Gets Active on False Hope
-
Pre-Open Stock Movers 06/04: (BRLI) (AVEO) (FIVE) Higher; (MCP) (DRWI) (OPK) Lower (more...)
-
After-Hours Stock Movers 06/03: (FIVE) (FEYE) (EYES) Higher; (DRWI) (SGMO) (BLUE) Lower (more...)
-
Market Wrap: May ADP Payroll Additions Edge Views; Trade Gap Narrows in April; Wendy's Gains on Buyback, Revised Outlook
-
Celgene and bluebird bio to Develop Anti-BCMA Product Candidates; bluebird bio Regains Rights to CAR T Programs Outside of BCMA
-
Celgene to Acquire Quanticel Pharmaceuticals
-
Celgene Corporation Enters into Strategic Immuno-Oncology Collaboration with AstraZeneca to Develop PD-L1 Inhibitor Program for Patients with Serious Blood Cancers
-
POMALYST® (pomalidomide) Label Update Including Progression-Free and Overall Survival Benefits Approved by U.S. FDA
-
Phase II Data for Apremilast in Behçet’s Disease Published in The New England Journal of Medicine
-
Celgene Corporation Elects Mr. Michael W. Bonney to Its Board of Directors
-
Celgene Corporation Announces the Appointment of Gerald F. Masoudi as Executive Vice President, General Counsel and Corporate Secretary Following the Retirement of Lawrence V. Stein
-
Celgene Corporation (Nasdaq: CELG) to Ring The Nasdaq Stock Market Closing Bell
-
Celgene Corporation (Nasdaq: CELG) to Ring The Nasdaq Stock Market Closing Bell
-
Positive Results from Phase III Study Evaluating Oral OTEZLA® (Apremilast) or Injectable Etanercept versus Placebo in Patients with Moderate to Severe Plaque Psoriasis Presented at AAD
-
Oral OTEZLA® (apremilast) Long-Term Safety and Efficacy Data in Patients with Moderate to Severe Plaque Psoriasis Presented at AAD
-
Phase II Data for Celgene’s Investigational Oral GED-0301 for Patients with Active Crohn’s Disease Published in New England Journal of Medicine
-
UPDATE: Gilead Sciences (GILD) Hits Session Lows
-
Notable Analyst Rating Changes 05/29: (TWTR) (PANW) (DHI) Upgraded; (CELG) (DG) (PAGP) Downgraded
-
Streetinsider.com's Hot Lunchtime Reads 05/27: (CTRL) (GTAT) (CELG) (RVBD)
-
Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index
-
Stocks Choppy With Escalation of Ukraine Violence
-
Stocks Sink; Margin Fears Take Center Stage
-
Blood-Bath in Nasdaq Stocks
-
Market Wrap: Yellen Up Next; Apple's Record App Store Sales; Micron Trumps Views
-
Notable Analyst Rating Changes 01/06: (SCTY) (BSX) (AIG) Upgraded; (TWTR) (AAPL) (SRPT) Downgraded
-
Pre-Open Stock Movers 10/16: (RCPT) (AAP) (MAT) Higher; (SWK) (MCP) (JOEZ) Lower (more...)
-
Celgene (CELG) Sees Upside on Chatter
-
Ariad (ARIA) May Have Been Best at ASH Meeting

